New Herpes Vaccine Nearing Human Clinical Trials
Published October 23, 2019 | Vaccination, Future Vaccines
Researchers at the University of Pennsylvania recently reported that
they are close to developing a herpes simplex virus 2 (HSV-2) vaccine
for humans. HSV-2 primarily causes genital herpes and is contracted
through forms of sexual contact with a person who has HSV-2. An
estimated 14 percent of
Americans between the ages of 15 and 49 are infected with HSV-2. According to Forbes, the goal of is to make the vaccine work in a similar manner to the current human papillomavirus (HPV) vaccine on the market.1 2 3
Previous attempts to develop a herpes vaccine have failed. However, according to a new study published in Science Immunology, an new experimental HSV-2 vaccine has prevented genital lesions in mice and guinea pigs. According to a report in New Scientist, the vaccine prevented low-level “hidden” infections. Other experimental vaccines initially thought to be promising enough to test in humans have failed to prevent these hidden infections in animals.4
Harvey Friedman, MD, who is a coauthor of the study and an immunologist at the University of Pennsylvania, is quoted as saying that, “This degree of protection is better than any other vaccine candidates have achieved in mice. We also had excellent protection in guinea pigs, which is another animal model used to evaluate genital herpes vaccine candidates.” He adds, “but we won’t know if this vaccine will work until it is tested in humans.”4
Dr. Friedman states that the new HSV-2 vaccine takes a genetics-based approach to preventing herpes transmission. It combines the messenger RNA (mRNA) coding for three proteins found in the virus.4
No mRNA-based vaccine has yet been approved for use in the United States. According to PHG Foundation at University of Cambridge, while RNA vaccines are non-infectious and RNA does not integrate itself into the host genome, the mRNA strand in an RNA vaccine “may elicit an unintended immune reaction.”4 5
Amesh Adalja, MD, a senior scholar at Johns Hopkins Center for Health Security, says, “the technology has the potential to totally change the face of vaccine development in terms of speed, ease of manufacture and pursuit of novel targets. The promising results seen with this mRNA vaccine in mouse and guinea pig model will hopefully move into human clinical studies and also further the rise of mRNA vaccine technology.”3
Dr. Friedman and his team are in negotiations with a biotechnology company to begin the first stage of human clinical trials in the next year with 50 to 100 people to first test the vaccine’s safety and its ability to produce an immune response.3
If the vaccine is successful in all stages of the human trials, Dr. Friedman said researchers envision it being recommended for children to the onset of sexual activity similar to recommendations for HPV vaccine routinely administered to pre-adolescents.3
References:
Americans between the ages of 15 and 49 are infected with HSV-2. According to Forbes, the goal of is to make the vaccine work in a similar manner to the current human papillomavirus (HPV) vaccine on the market.1 2 3
Previous attempts to develop a herpes vaccine have failed. However, according to a new study published in Science Immunology, an new experimental HSV-2 vaccine has prevented genital lesions in mice and guinea pigs. According to a report in New Scientist, the vaccine prevented low-level “hidden” infections. Other experimental vaccines initially thought to be promising enough to test in humans have failed to prevent these hidden infections in animals.4
Harvey Friedman, MD, who is a coauthor of the study and an immunologist at the University of Pennsylvania, is quoted as saying that, “This degree of protection is better than any other vaccine candidates have achieved in mice. We also had excellent protection in guinea pigs, which is another animal model used to evaluate genital herpes vaccine candidates.” He adds, “but we won’t know if this vaccine will work until it is tested in humans.”4
Dr. Friedman states that the new HSV-2 vaccine takes a genetics-based approach to preventing herpes transmission. It combines the messenger RNA (mRNA) coding for three proteins found in the virus.4
No mRNA-based vaccine has yet been approved for use in the United States. According to PHG Foundation at University of Cambridge, while RNA vaccines are non-infectious and RNA does not integrate itself into the host genome, the mRNA strand in an RNA vaccine “may elicit an unintended immune reaction.”4 5
Amesh Adalja, MD, a senior scholar at Johns Hopkins Center for Health Security, says, “the technology has the potential to totally change the face of vaccine development in terms of speed, ease of manufacture and pursuit of novel targets. The promising results seen with this mRNA vaccine in mouse and guinea pig model will hopefully move into human clinical studies and also further the rise of mRNA vaccine technology.”3
Dr. Friedman and his team are in negotiations with a biotechnology company to begin the first stage of human clinical trials in the next year with 50 to 100 people to first test the vaccine’s safety and its ability to produce an immune response.3
If the vaccine is successful in all stages of the human trials, Dr. Friedman said researchers envision it being recommended for children to the onset of sexual activity similar to recommendations for HPV vaccine routinely administered to pre-adolescents.3
References:
ReplyDeleteDr Oduku Herbal Healing Centre we offer you the best organic herbs and natural remedies to all kind of diseases, We understand disease at a level beyond the superficial symptoms and strive to find a permanent resolution. Together with the patient, we aim to bring about a state of absolute health in everyone who consults us. we have studied the natural properties of natural herbs , their remarkable benefits, and developed a unique range of drops, capsules, bottle herbs and dried herbs. We have employed scientific testing methods and modern extraction processes to ensure the benefits of the herbs remain intact, all this at a very good price and excellent quality. We ship worldwide.contact us today to get rid of any form STD and infection's VIA odukuherbalremedies@gmail.com or WhatsApp +2349064430408
ReplyDeleteI want to use the means to thank Robinson.buckler for his good work I have been very sick with this horrible diseases for 9 months they all tell me there was no cure for me I have go to different hospital I always have same news, I was confused because I feel like ending my life that time thank God I was able to locate doctor Robinson.buckler who help me I found his email on site how people was writing Good about him I never believe he can really cured me until when I get my test done. I am so happy to tell you this Robinson.buckler have a herbal cure to Herpes and you can take the medicine according to his instruction you will found out that you will give testimony like me I take his herbal medicine for just 2 week. I am so happy today that I am really free from this sickness here is Robinson.buckler email Robinson.buckler (( @yahoo. com ))………………………………. you can reach him out now https://robinbuckler.com/